FDA Warning Letter — Octapharma USA, Inc.
The FDA took a Warning Letter action against Octapharma USA, Inc. on May 17, 2012 (Paramus, NJ). The action was issued by CBER and concerns biologics products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Octapharma USA, Inc.
- Date
- May 17, 2012
- Fiscal Year
- 2012
- Product Type
- Biologics
- Center
- CBER
- Location
- Paramus, NJ (United States)